Search

Released in partnership with the Desert Research Institute: New research from the Healthy Nevada Project® finds that a confirmed diagnosis does not always result in changes to patient care. Presenting individuals with potentially life-altering health information doesn’t mean the individuals – or their healthcare providers – will act on it. Follow-up education and conversations about actionable care plans with patients and their doctors are key next steps, according to new research from the Healthy Nevada Project.  The Healthy Nevada Project is a genetic screening and research project that launched in 2016 as a partnership between DRI and Renown Health. The project now has more than 50,000 participants, with genetic sequencing provided by Helix.  Between September 2018 and September 2020, the Healthy Nevada Project successfully notified 293 participants that they were genetically at risk for hereditary breast and ovarian cancer syndrome, Lynch syndrome, or familial hypercholesterolemia – three common genetic conditions known collectively as the Centers for Disease Control and Prevention (CDC) Tier 1 conditions. In a study published today in Frontiers in Genetics, Healthy Nevada Project scientists looked at the impact that notifying a patient of a positive finding for a CDC Tier 1 condition had on the care that the patient received in the months and years that followed.  According to their results, among the 293 Healthy Nevada Project participants who were notified of their genetic risk of a CDC Tier 1 condition, 71 percent of participants with electronic health records shared their findings with healthcare providers. However, only 30 percent of the electronic health records for these patients contained documentation of the genetic diagnosis, and only 10 percent of examined patients experienced a possible change in care after receiving the results of their genetic screening.  “The Healthy Nevada Project was implemented with a ‘hands-off’ approach where the participants receive their findings and decide with whom and when to share those findings. The findings were not automatically added to their electronic health records,” said Dr. Gai Elhanan, health data scientist at DRI and co-lead author of the study. “What we’re learning now is that to ensure that important genetic findings are integrated into the care journey it is important to make their inclusion into the electronic health records part of the study.” This study builds on previous Healthy Nevada Project research published in Nature Medicine demonstrating the importance of screening for CDC Tier 1 conditions, which affect about one in 75 individuals and can be mitigated or even prevented from developing into disease when detected early. This study found that as many as 90 percent of the CDC Tier 1 cases are missed by clinical providers during normal clinical care screenings and examinations. During the current study, the Healthy Nevada Project scientists found that 19 percent of studied participants had already developed one of the CDC Tier 1 conditions, and thus would have potentially benefited from earlier notification about their condition. The study team hopes that their findings will encourage individuals in Nevada to obtain genetic testing for these relatively common conditions. Even if individuals are older or have already suffered from diseases related to these conditions, testing could also prove beneficial to siblings, children, and grandchildren who may also be at risk and who could subsequently be screened in the event of a positive finding. The study team also encourages informing health care providers of the importance of incorporating genetic diagnoses into the pharmaceutical (for example, for Familial Hypercholesterolemia) and treatment advice given to patients.  “As a result of this analysis, the clinicians at Renown Health and the Healthy Nevada Project researchers have made significant changes, including obtaining informed consent from participants to report positive findings from their genetics reports directly into their electronic medical record,” said Daniel Kiser, M.S., assistant research scientist of data science at DRI and co-lead author of the study. “This will help both participants, their clinical providers, and the whole state maximize the long-term benefits of the Healthy Nevada Project voluntary population-based genetic screening.” Additional information: The full text of the study,  Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, is available from Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169.  This project was funded by Renown Health, the Renown Health Foundation, and the Nevada Governor’s Office of Economic Development. Study authors included Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix), and Joseph Grzymski (DRI/Renown Health). For more information on the Healthy Nevada Project® or to request genetic screening, please visit: https://healthynv.org/ About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit www.dri.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.

Read More About Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result

Recognized as national leader in LGBTQ+ care by Human Rights Campaign Foundation for 2022 All people who need medical care should be able to see their doctor or have a hospital visit without worrying about being mistreated, harassed or denied service outright. Data from the national CAP survey shows that LGBTQ+ people experience discrimination in healthcare settings; and that discourages them from seeking needed care. These results highlight the importance of protecting LGBTQ+ people from discrimination in healthcare. Renown Health and UNR Med caregivers, supported by community LGBTQ+ and Transgender Allies and partners, are working to bridge the gap for LGBTQ+ patients and families, and to become a more inclusive organization. This week, the Human Rights Campaign Foundation recognized Renown Regional Medical Center in Reno, Nev. as the first and only hospital in Nevada designated with a perfect score, and at the highest level of support as “LGBTQ+ Healthcare Equality Leader.” The Healthcare Equality Index (HEI) is the nation’s foremost benchmarking survey of healthcare facilities on policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees. We constantly strive to be among the best in the nation for quality, safety and patient experience," said Dr. Thomas Graf, interim CEO and Chief Clinical and Quality Officer. "This recognition confirms what the Renown Health team is dedicated to – providing the best patient care possible. Quality and safety are the responsibility of every employee and physician at Renown, and we are proud that the Renown Regional Medical Center team has been chosen among the best in the state and nation for our commitment to LGBTQ+ patient-centered care.” “Renown Health is proud to join the state of Nevada, which also earned top rankings on the Human Rights Campaign State Equality Index, and the City of Reno on the Municipal Equity Scorecard for LGBTQ+ equality,” said Sy Johnson, MBA, interim president and Chief of Staff. “The Human Rights Campaign HEI offers a powerful way for organizations to affirm that they are committed to LGBTQ+ patient-centered care and extend non-discrimination protections to our LGBTQ+ employees, who play a key role in ensuring sensitive, knowledgeable LGBTQ+ care.” “We at UNR Med are so proud to be partners with Renown in this effort,” said Nicole Jacobs, Ph.D. (she/her/hers)Associate Dean, Diversity and Inclusion; Clinical Psychologist / Professor; Department of Psychiatry and Behavioral Sciences at UNR Med. “The designation of being an LGBTQ+ Healthcare Equity Leader demonstrates Renown’s strong commitment to advancing equitable healthcare in Nevada, our core and shared values and our shared mission of addressing the healthcare disparities in our backyards.” A record 906 healthcare facilities actively participated in the 2022 HEI survey and 496 of those earned an “LGBTQ+ Healthcare Equality Equality Leader” designation. Renown Regional Medical Center is the first and only hospital in Nevada recognized by the Human Rights Campaign. No other hospitals in the state met their stringent standards for the 2021 rankings. “Every person deserves to have access to quality healthcare, be respected and heard by their doctor and feel safe in the facility where they are receiving care,” said Tari Hanneman, (she/her) Director of Health & Aging at The Human Rights Campaign. “The Healthcare Equality Index, at its core, strives to ensure LGBTQ+ people are protected and affirmed by their healthcare providers and feel safe seeking services. Our HEI active participants are truly pioneering the healthcare industry by implementing robust, comprehensive LGBTQ+ inclusive policies that hopefully, because of their work, will become standard practice The HEI evaluates and scores healthcare facilities on detailed criteria falling under four central pillars: Foundational Policies and Training in LGBTQ+ Patient-Centered Care LGBTQ+ Patient Services and Support Employee Benefits and Policies Patient and Community Engagement Suzanne Hendery, MA, APR, Chief Customer Officer, who led Renown’s application process, noted the remarkable progress reflected in the team 2022 HEI submission includes: Updated Medical Records with Preferred Name and Pronouns. Kathleen Zaski, BSN, RN, Director of IT Applications explains why this is so important. “Your name and identity are core to who you are as a person, and here at Renown, we aim to take care of you as a whole person and to provide the highest level of quality care to our community – all while ensuring the experience is exceptional and tailored to the individual. Our medical records system supports our doctors, nurses and care team in capturing this vital information. We are now able to capture every person’s preferred name, sex and sexual orientation to better care for them.” Allowing visitation without regard to sexual orientation or gender identity. Whitney Hansen, PhD, Director of Service Excellence says, “I know how important it is to our patients and their families that Renown serves our entire community and that we provide a welcoming, safe space and sense of belonging to all. We are proud of Renown’s visitor policy, inspired by family members, who requested that the policy encourage two family members per day be able to visit a loved one hospitalized at Renown.” Gender Neutral Restrooms. Chris Baker, CHFM, Director Facilities Engineering, whose team has created over 48 gender-neutral restrooms across Renown says, “Ensuring that private restrooms are equally available to everyone on our campus is just one way we can provide a more inclusive, caring space for the people we serve.” In addition, Renown clinicians and caregivers received recognition in the following areas: Every staff member receives training in LGBTQ+ patient-centered care Both “sexual orientation” and “gender identity” are included in both the patient non-discrimination policy and in Renown’s employment nondiscrimination policy Offering transgender-inclusive healthcare benefits to employees and members of Renown’s not-for-profit health plan, Hometown Health Providing substantial support and awarding grants to area organizations addressing diversity and inclusion, LGBTQ+ community Pride events and collaboration with LGBTQ+ organizations as an ally “I’m extremely proud of the people I get to work with every day who make achievements like this possible, says Brian Colonna CHC, CHPC, CHRC, Director of Compliance. “This is a meaningful designation, said Bethany Sexton, MA, Chief Transformation Officer. “I feel so proud to be part of a team and organization that helps translate our mission as an organization into action that matters for every member of our community.” Mitch Harper, Director of Network Performance, said, “We have just begun on this journey. We recognize there is still so much more to improve upon in becoming an inclusive organization. We are working to create a safe and welcoming environment for our community and our employees. Access to basic human services should not be contingent on an individual’s skin color, ethnicity, sex, gender identity, sexual orientation, age, disability, or beliefs.” Sean Savoy, Manager of Spiritual Care at Renown said, “Good news indeed! So glad that Renown Health has achieved this milestone with HRC – a leader in civil rights for sexual orientation-gender identity minorities. I look forward to the continuing work around striving to achieve clinical equity, cultural competency, and respect for our LGBTQIA patients and employees.” For more on LBGTQ+ care and providers at Renown, visit renown.org/diversity/lbgtq-at-renown/ Join the Renown team Renown Health is now hiring key roles in our organization to support the health and well-being of our community. To join the Renown family to Fight the Good Fight, apply on line at careers.renown.org/ About the Human Rights Campaign Foundation The Human Rights Campaign Foundation is the educational arm of the Human Rights Campaign (HRC), America's largest civil rights organization working to achieve equality for lesbian, gay, bisexual, transgender and queer (LGBTQ+) people. Through its programs, the HRC Foundation seeks to make transformational change in the everyday lives of LGBTQ+ people, shedding light on inequity and deepening the public’s understanding of LGBTQ+ issues, with a clear focus on advancing transgender and racial justice. Its work has transformed the landscape for more than 15 million workers, 11 million students, 1 million clients in the adoption and foster care system and so much more. The HRC Foundation provides direct consultation and technical assistance to institutions and communities, driving the advancement of inclusive policies and practices; it builds the capacity of future leaders and allies through fellowship and training programs; and, with the firm belief that we are stronger working together, it forges partnerships with advocates in the U.S. and around the globe to increase our impact and shape the future of our work. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Renown Regional Named Health Equity Leader for Nevada

Medical Students Recognize Transgender Lives Lost to Violence, Address Inequities in Health The month of November includes Transgender Awareness Week, which concludes with Transgender Day of Remembrance (TDOR), on Sunday, November 20, a day for people to come together to recognize the many transgender lives lost to violence over the last year. Transgender people remain one of the most underserved groups of people across several domains, including health care. The Transgender Day of Remembrance and Resilience memorializes people who have passed due to transphobic violence. The Transgender community is an umbrella term used by people who do not identify with the gender associated with the sex they were assigned at birth. Not everyone identifies with the term transgender, and there are many self-identifier terms for people who do not identify with their assigned sex at birth (e.g., woman, man, trans, non-binary, gender nonconforming, gender fluid, gender queer, and more). Transgender Day of Remembrance is held in November to honor Rita Hester, whose murder on Nov. 28, 1998, launched the “Remembering Our Dead” web project and a San Francisco vigil the following year. The event provides a forum for transgender communities and allies to raise awareness of the threat of violence faced by gender variant people and the persistence of prejudice felt by the transgender community. Communities organize events and activities including town hall style "teach-ins," photography and poetry exhibits and candlelit vigils. These activities make anti-transgender violence visible to stakeholders like police, the media, and elected officials. In 2010, TDoR was observed in over 185 cities throughout more than 20 countries. Here in Reno, the University of Nevada, Reno School of Medicine (UNR Med) hosts Diversity Dialogues, a series hosted by the Office of Diversity and Inclusion. This month, the Medical Student Pride Alliance of UNR Med honored transgender people whose lives were lost in acts of anti-transgender violence, that included a medical student-led discussion regarding ways to help raise visibility and awareness for transgender people and the issues faced by the community. Diversity Dialogues is an open discussion of diversity and inclusion issues and the diversity initiatives at UNR Med. The UNR Med Diversity Dialogues included a reading of the names of those who died from October 1st of the former year to September 30th of the current year, and education on transgender and gender non-conforming people. Medical students recommend ways that healthcare providers can help support the community including: Being open to feedback, criticism, and new information Contributing to a LGBTQ+ safe space by using pronoun pins, flags, inclusive language Registering your practice on Nevada Gender Affirming Healthcare Project (NGAHP), GLMA: Health Professionals Advancing LGBTQ Equality, Outcare Health, & other provider lists Reading new research in academic journals and stay up to date with guidelines including World Professional Association for Transgender Health (WPATH) Version 8 and attending CME courses on LGBTQ+ Care. The general public can support the community by: Standing up for trans people in your life, in the media, and amongst your peers, and be an active, proud ally to the community Respecting people’s identities and fluidity and learn to use different pronouns Consuming trans-friendly and LGBTQ+ friendly media (tv shows, movies, music, podcasts) Following trans people on social media, specifically activists/educators, to learn from them This month, the Human Rights Campaign (HRC) Foundation, the educational arm of the Human Rights Campaign, the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, released “An Epidemic of Violence: Fatal Violence Against Transgender and Gender Non-Conforming People in the United States in 2022” a report honoring the lives of at least 32 transgender and gender non-conforming people killed in 2022 and shining a light on data that HRC has continued to collect on the epidemic of violence. HRC has officially recorded at least 300 violent deaths of transgender and gender non-conforming people, including 32 in 2022 alone, since the organization began tracking this violence ten years ago. Overall, transgender and gender non-conforming victims of violence are overwhelmingly Black, under 35, and killed with a firearm. The highest known single-year total of fatal deaths of transgender and gender non-conforming people was in 2021, when at least 57 trans & gender non-conforming people were violently killed. Worse, these disturbing numbers likely underreport the deadly violence targeting transgender and gender non-confirming people, who may not be properly identified as transgender or gender non-conforming by police, media or other sources. In 2022, the Human Rights Campaign Foundation recognized Renown Regional Medical Center in Reno, Nev. as the first and only hospital in Nevada at the highest level of support as “LGBTQ+ Healthcare Equality Leader.” The Healthcare Equality Index (HEI) is the nation’s foremost benchmarking survey of healthcare facilities on policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees. For more on LBGTQ+ care and providers at Renown, visit renown.org/diversity/lgbtq-at-renown/. The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is Nevada's largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children's hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health.

Read More About UNR Med and Renown Health Recognize Transgender Day of Remembrance

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)